Related by context. All words. (Click for frequent words.) 73 anti CD# monoclonal 72 humanized antibody 70 humanized anti 69 CD# antibody [001] 69 antibody fragment 68 cleavable linker 68 humanized monoclonal 68 replicon 67 humanized monoclonal antibodies 67 anti CD3 67 targeting CD# 67 immunostimulatory 66 thrombin receptor 66 immunotherapeutic 66 proteasome inhibitor 66 humanized monoclonal antibody 66 antisense oligonucleotide 66 Fc fusion protein 66 liposomal formulation 66 NOD SCID mice 66 drug conjugate 66 VitiGam 65 monoclonal antibody 65 bispecific 65 CYC# 65 bispecific antibody 65 monoclonal antibody mAb 65 targeted antifolate 65 Factor VIIa 65 selective inhibition 65 camptothecin 65 chimeric monoclonal antibody 65 TLR9 agonist 65 synthetic peptide 65 PDE4 inhibitor 65 immune modulating 65 cytoprotective 64 orally bioavailable 64 potent cytotoxic 64 human monoclonal antibody 64 anti CD# antibodies 64 BiTE 64 CD# monoclonal antibody 64 DXL# 64 PEGylated 64 adenoviral vectors 64 antibody 64 immunomodulatory properties 64 Enkephalin 64 immunotoxin 64 Radilex 64 JAK3 64 Litx 63 IAP inhibitor 63 immunomodulator 63 siRNAs targeting 63 soluble tumor necrosis 63 OncoVEX 63 MAXY G# 63 immune modulator 63 adenoviral 63 Onconase 63 fusion protein 63 polymerase inhibitor 63 antitumoral 63 ErbB3 63 mertansine 63 oral antiviral 63 orally dosed 63 histone deacetylase inhibitor 63 telomerase inhibitor 63 AVP #D# 63 MVA BN R 63 oral prodrug 63 JAK inhibitor 63 investigational humanized monoclonal antibody 63 SAR# [004] 63 VEGF receptor 63 immunoconjugate 63 Tarvacin 63 factor G CSF 63 therapeutic monoclonal antibodies 63 interferon lambda 63 alpha interferon 63 recombinant fusion 63 AQ4N 63 polyclonal 63 tumor antigen 63 monoclonal 63 NTDDS 63 CTLA 4 63 plasmid encoding 63 epothilones 62 protein tyrosine phosphatase 1B 62 AEG# 62 polyclonal antibody 62 antisense inhibitor 62 cytostatic 62 histone deacetylase HDAC 62 potently inhibit 62 oncolytic 62 Tarvacin TM 62 somatostatin analogue 62 novel peptide 62 NEUGENE 62 HCV protease inhibitor 62 RAF kinase 62 monoclonal anti 62 cytolytic 62 Micromet BiTE 62 GRNVAC1 62 cancer immunotherapies 62 JAK inhibitors 62 anti neoplastic 62 Maxy G# 62 MAGE A3 ASCI 62 androgen receptor AR 62 siRNA therapeutic 62 JAK1 62 recombinant adeno associated 62 anti CD3 monoclonal 62 ESBA# 62 albumin binding 62 MVA BN 62 isotype 62 immune stimulatory 62 selective agonist 62 C5aR 62 selective inhibitor 62 HER2/neu 62 auristatin 62 NPC 1C 62 IMA# 62 epothilone 62 immune modulatory 62 selective modulator 62 vascular disrupting agents 62 monoclonal antibodies 62 annexin V 62 chemokine receptor 62 Cyclosert 62 HCV polymerase 62 EGF receptor 62 Aurora kinase inhibitor 62 BAL# [001] 62 MEK inhibitors 62 neuraminidase inhibitor 62 JAK2 inhibitor 62 milatuzumab 62 PNP inhibitor 62 Anticalins R 62 isoform selective 62 PI3K inhibitor 61 hA# 61 Cathepsin S 61 ADP receptor antagonist 61 nanoviricide 61 ENMD # 61 A3 adenosine receptor 61 NEUMUNE 61 CDK inhibitor 61 IAP inhibitors 61 CCR2 61 HuLuc# 61 prodrugs 61 ectodomain 61 Protexia 61 small molecule activators 61 CCX# 61 DNA intercalator 61 antibody MT# 61 L asparaginase 61 Gleevec resistant 61 potent antiproliferative 61 humanized antibodies 61 Anticalins ® 61 Fibroblast Growth Factor Receptor 61 DepoVax TM 61 Protein Kinase C 61 rxRNA 61 mAbs 61 antibody MAb 61 HuMax CD4 61 oncolytic virus 61 Aurora Kinase 61 T#I [002] 61 thymidylate synthase TS 61 antiangiogenic 61 depsipeptide 61 ATL# [001] 61 IgG1 61 immunotoxins 61 Epidermal Growth Factor Receptor 61 Annexin V 61 Elvitegravir 61 orally bioavailable mimics 61 tyrosine kinase inhibitor 61 busulfan 61 Apoptone 61 tumorigenicity 61 MGd 61 MTP inhibitor 61 GM CSF 61 menadione 61 OncoVEX GM CSF 61 Guanilib 61 protein kinase inhibitor 61 immunomodulating 61 Multimeric 61 Virulizin ® 61 recombinant subunit vaccine 61 novel anticancer 61 Leukine ® 61 activin 61 PKC# 61 HCD# [002] 61 XmAb# 61 NR2B subunit 61 mu opioid receptor antagonist 61 interleukin IL -# 61 huC# DM4 61 non nucleoside 61 rhMBL 61 c MET 61 cellular cytotoxicity 61 Valortim R 61 CD# antibodies 61 secretase 61 CTLs 61 selective adenosine 61 Valortim ® 61 recombinant FVIII 61 cytidine 61 vidofludimus 61 Panzem 61 stable linker 61 fusion proteins 61 glycosylated 61 Personalized Immunotherapy 61 geldanamycin 61 recombinant antibodies 61 liposomal 61 myelofibrosis polycythemia vera 61 pan HDAC inhibitor 61 cancer vaccine Norelin 61 Chemokine Receptor 61 targeted radiotherapeutic 61 bispecific antibodies 61 Xanafide 61 UniBody 61 anti angiogenic 61 peripherally acting 61 orally administered inhibitor 61 HepaGam B 61 TGF beta1 60 HDACi 60 OHR/AVR# 60 M1 muscarinic 60 Histone deacetylase 60 immunomodulatory 60 IMC #B 60 gastrin 60 PRT# 60 vWF 60 Marqibo TM 60 allogeneic cell 60 enkephalin 60 sodium glucose cotransporter 60 HuMax CD# 60 HSP# inhibitor 60 Traficet EN 60 pharmacological chaperone 60 purified recombinant 60 Pralatrexate 60 tyrosine kinase receptor 60 Granulocyte Colony Stimulating Factor 60 Enzastaurin 60 c myc 60 Dapagliflozin 60 therapeutic monoclonal antibody 60 EGFR TKIs 60 selective antagonist 60 virosomes 60 PSMA antibody 60 lentiviral vector 60 antifibrotic 60 CRAC channel 60 anticancer therapeutics 60 intranasal formulation 60 TRX1 60 HCV protease inhibitors 60 DGAT1 60 tumorigenic 60 C5a 60 interferon IFN 60 SMaRT ™ 60 Thiovir 60 FLT3 60 MyVax R 60 Cytotoxic T 60 adenoviral vector 60 Insegia 60 ERK1 2 60 novel topoisomerase 60 flavopiridol 60 chimeric antibody 60 ATL# [002] 60 XmAb 60 CD3 monoclonal antibody 60 hypoxia inducible factor 60 mTOR inhibitors 60 Urokinase 60 tubulin binding 60 constitutively active 60 prodrug 60 BiTE antibody 60 anticancer agent 60 chemotherapy induced neutropenia 60 PSMA ADC 60 M2 subunit 60 anti EGFR antibody 60 2DG 60 LEX System 60 protein tyrosine phosphatase 60 immunomodulatory effects 60 ActA 60 CXCR4 receptor 60 TGR5 60 proteasome inhibitors 60 virus AAV 60 heparanase 60 SynCon 60 antigen sparing 60 enzyme inhibitor 60 PDGF receptor 60 TNFa 60 colon carcinoma 60 PI3 kinase 60 irreversible inhibitor 60 lentiviral vectors 60 chemically modified siRNA 60 NS4A 60 nanoparticle formulation 60 CCR9 antagonist 60 Liposomal 60 Pimavanserin 60 MAb 60 erlotinib Tarceva 60 AVI NEUGENE 60 BRAF kinase 60 GW# [003] 60 TLR9 agonists 60 effector function 60 phosphatidylserine PS targeting 60 HCV NS3 protease 60 metaglidasen 60 Luteinizing Hormone Releasing Hormone 60 receptor tyrosine kinase inhibitor 60 Medarex UltiMAb R 60 lipopeptide 60 microtubule inhibitor 60 nicotinic alpha 7 60 Epothilones 60 calcitonin gene related 60 recombinant plasma 60 binds selectively 60 antisense inhibitors 60 Angiolix 60 Sym# 60 corticosteroid dexamethasone 60 PEGylated Fab fragment 60 PEGylated interferon 60 ALN TTR# 60 adenovirus vector 60 immunotherapeutics 60 alkylating agent 60 potent anticancer 60 trastuzumab DM1 T DM1 60 MMAE 60 biased ligand 60 peptide antigens 60 gamma secretase inhibitors 59 kinase inhibitor 59 PTP 1B 59 AAV vector 59 mediated inhibition 59 KSP inhibitors 59 inhibit replication 59 HuCAL antibody 59 Phase #b/#a clinical 59 personalized immunotherapy 59 mda 7 59 poly ADP ribose polymerase 59 Blinatumomab 59 rBChE 59 TKM ApoB 59 MGCD# [001] 59 myeloma cells 59 immunomodulators 59 fusion inhibitor 59 hESC derived 59 beta 1a 59 Protectan CBLB# 59 BiTE ® 59 RNA antagonist 59 vinorelbine tartrate 59 apoptotic pathway 59 potent topoisomerase II 59 retinoic acid receptor 59 Milatuzumab 59 Scancell 59 pDCs 59 SMARTICLES ® 59 antiproliferative activity 59 P#X# 59 FVIII 59 CCR5 antagonist 59 SGLT2 59 annexin 59 Vegenics 59 OMP #M# 59 reslizumab 59 HepDirect prodrug 59 gamma secretase inhibitor 59 novel prodrug 59 Aplidin 59 NF kB Decoy 59 HER2 receptor 59 Syk kinase 59 CRTH2 59 GeneICE 59 cyclin dependent kinase inhibitor 59 adenovector 59 systemically administered 59 BiTE R 59 radiation sensitizer 59 viral antigen 59 mAb 59 adenosine A2A 59 trabectedin 59 Dacogen decitabine 59 antisense oligonucleotides 59 BAY #-# 59 JAK#/JAK# 59 tipifarnib 59 Nanobody 59 NF kB pathway 59 RNAi therapeutic targeting 59 selectively inhibits 59 beta lactamase inhibitor 59 butyrylcholinesterase 59 prostanoid 59 enzyme inhibitors 59 lentiviral 59 potent inhibition 59 potent inhibitor 59 pro angiogenic 59 NS5A 59 plasmacytoid dendritic cells 59 cathepsins 59 stable nucleic acid 59 antitumor 59 SERMs 59 PI3 kinase inhibitors 59 CD# expressing 59 small molecule tyrosine 59 PI3K/mTOR 59 LNP formulations 59 midkine 59 Tumor Necrosis Factor 59 HQK 59 Vascular Endothelial Growth 59 conjugates 59 MVA BN ® 59 DepoVax 59 ddRNAi 59 Pertuzumab 59 murine monoclonal antibody 59 investigational monoclonal antibody 59 peptidomimetic 59 histone deacetylase HDAC inhibitor 59 deacetylase inhibitors 59 IMPDH 59 EndoTAG TM 59 Daclizumab 59 selectively inhibited 59 Temsirolimus 59 HGS ETR2 59 DNA methyltransferases 59 theranostic 59 TLR agonists 59 GVAX ® 59 erlotinib Tarceva ® 59 zanolimumab 59 PEGPH# 59 demethylating agents 59 clinically validated targets 59 HER1 59 Squalamine 59 MKC# MT 59 Factor VEGF 59 CCR9 59 intravenously administered 59 oncolytic viruses 59 TLR8 59 M2e 59 CCR1 59 muscarinic antagonist 59 mature dendritic cells 59 topoisomerase II inhibitor 59 oral Hsp# inhibitor 59 TELINTRA 59 Proxinium TM 59 cilengitide 59 IL #p# 59 GelSite R polymer 59 NS#/#A protease 59 Pentraxin 2 59 Aurora kinase 59 HuMax HepC TM 59 Antiangiogenic 59 hTERT 59 LEAPS TM 59 lipid nanoparticle 59 miR #a [002] 59 PPARgamma 59 IgG1 antibody 59 CEQ# 59 radiolabeled 59 hepatoma 59 virosome 59 DOS# 59 PEG SN# 59 potently inhibited 59 antisense drug 59 hapten 59 oral ghrelin agonist 59 adhesion molecule 59 syngeneic 59 IFN alpha 59 Hsp# inhibitor 59 therapeutic antibody 59 sphingosine 1 59 peptide CGRP 59 maturation inhibitors 59 Alfacell proprietary ribonuclease 59 Orally administered 59 PROCHYMAL 59 entinostat 59 bifunctional 59 C. difficile toxins 59 SAR# [002] 59 ZFP TF 59 HCV RNA polymerase 59 selective agonists 59 TNF α 59 cyclin E 59 brostallicin 59 resolvins 59 Xcellerated T Cells 59 polymerase inhibitors 59 phosphorylate 59 factor Xa 59 Trastuzumab 59 PLA2 59 IV Busulfex 59 cathepsin B 59 Homspera TM 59 HuMax TAC 59 AMPK activators 59 Acute Radiation Syndrome ARS 59 Homspera 59 Phylomer 59 MT#/MEDI-# 59 Protexia R 59 Tumor necrosis factor 59 redox active 59 Aplidin R 59 PXD# 59 vinca alkaloid 59 LNCaP cells 59 murine model 59 VEGF inhibitors 59 integrin receptors 59 drug zotarolimus 59 Epratuzumab 59 CD#L 59 CD4 + T lymphocytes 59 solithromycin 59 highly immunogenic 59 TRAIL receptors 59 Monoclonal 59 potent antibacterial 59 EndoTAG TM -1 59 inhaled formulation 59 HER-2/neu 59 Euroscreen 59 uPA 59 BRAF inhibitors 59 kallikrein 59 XL# XL# 59 Azedra 58 AKT inhibitor 58 insulin sensitizer 58 HSP# inhibitors 58 alpha folate receptor 58 JAK2 inhibitors 58 volociximab 58 cathepsin K inhibitor 58 synthetic analogues 58 EZN 58 cytotoxic T lymphocyte 58 beta amyloid peptide 58 aptamer 58 Fleximer 58 AGS PSCA 58 transfection reagents 58 histone deacetylase inhibitors 58 dimerization 58 monoclonal antibody MAb 58 iRGD 58 nucleotide analog 58 acetylcholinesterase AChE 58 Maribavir 58 NXL# 58 mitogen activated ERK kinase 58 sphingolipid 58 systemic RNAi therapeutic 58 peptidic 58 polyclonal antibodies 58 mGluR2 NAM 58 ® C1 esterase 58 BAL# [002] 58 Archexin 58 HCV replicon 58 RiVax 58 diarrhea predominant irritable 58 recombinant polyclonal antibody 58 #ME# 58 benzimidazole 58 anticancer therapies 58 novel histone deacetylase 58 MEK inhibitor 58 epratuzumab 58 cytomegalovirus CMV 58 tiapamil 58 E3 ligase 58 rhITF 58 OXIGON TM 58 PKM2 58 VSV G 58 maturation inhibitor 58 opioid receptor antagonist 58 selective androgen receptor modulator 58 selectively inhibit 58 FGFR 58 IL #E 58 mitotic kinesin 58 FUS1 58 Ceflatonin 58 JAK2 enzyme 58 Anavex #-# 58 erythropoietic 58 novel immunotherapeutic 58 non nucleoside HCV 58 KSP inhibitor 58 Anticalin R 58 DiLA2 58 chemokine receptors 58 DispersinB ® 58 Interferon alpha 58 immunotherapeutic vaccine 58 Tyrima 58 Monoclonal antibody 58 factor TNF receptor 58 aurora kinase 58 EndoTAG 58 dihydrofolate reductase 58 fosbretabulin 58 Tß4 58 investigational pan BCR 58 antiapoptotic 58 highly selective inhibitor 58 extracellular domain 58 Mipomersen 58 selectively inhibiting 58 Anticalin ® 58 Interferon gamma 58 beta interferons 58 PI3K/Akt pathway inhibitor 58 maytansinoid 58 anti CD3 antibody 58 ketolide antibiotic 58 osteogenic 58 Voreloxin 58 ADAMTS# 58 RNase H 58 Onalta 58 oral dihydropyrimidine dehydrogenase DPD 58 Recombinant 58 Genentech Rituxan 58 triphendiol 58 p# inhibitor 58 antibody fragments 58 small molecule inhibitors 58 poly ethylene glycol PEG 58 non nucleoside inhibitor 58 humanised monoclonal antibody 58 Angiocept 58 Cytochrome P# 58 PPARγ 58 scFv 58 immune modulators 58 Th# 58 dacetuzumab 58 THR beta agonist 58 ARIKACE ™ 58 GRN#L 58 IGF 1R inhibitor 58 TG# [003] 58 superantigens 58 Locked Nucleic Acid LNA 58 EGFP 58 Immunohistochemical analysis 58 Kinase Inhibitor 58 BChE 58 mGluR 58 cyclin dependent kinase CDK 58 Kinoid 58 meropenem 58 GRN# 58 Aviptadil 58 immatics 58 juvenile chondrocytes 58 HDAC 58 platinum chemotherapeutic 58 tumor antigens 58 CDP# 58 Curaxin CBLC# 58 proprietary polysaccharide 58 Fc receptor 58 p# mitogen activated 58 attenuated smallpox vaccine 58 oral proteasome inhibitor 58 FVIIa 58 mGluR2 58 accumulate preferentially 58 veltuzumab 58 potent anti angiogenic 58 vascular disrupting 58 EGFr 58 tranilast 58 TBC# 58 inhibiting tumor 58 Solazed TM 58 OncoVex 58 preclinically 58 lysophosphatidic acid LPA 58 biologic therapeutics 58 MAbs 58 MyVax ® 58 SIRT2 58 Vidofludimus 58 Akt activation 58 seliciclib 58 IGF1R 58 dAbs 58 hypoxia activated prodrug 58 PDE4 inhibitors 58 TNFα 58 antiproliferative effects 58 Bezielle 58 monocytes macrophages 58 plasmin 58 subcutaneous formulation 58 LHRH receptor positive 58 LHRH receptor 58 anticoagulant reversing agent 58 thymidine 58 biologic pathway 58 thrombopoietin 58 5 HT4 receptor 58 polysaccharide polymer 58 MorphoSys proprietary 58 histone deacetylase 58 PARP inhibitor 58 Cytotoxic 58 GelSite polymer 58 Lixivaptan 58 HCV polymerase inhibitor 58 Curaxins 58 Bavituximab 58 ABL inhibitor 58 intravesical instillation 58 idiotype 58 nanopharmaceutical 58 Curaxin 58 K ras mutations 58 Cdc7 58 SMARTICLES 58 cellular immunotherapy 58 IMVAMUNE TM 58 AT1R 58 Tarceva TM 58 tumor specific antigen 58 IgG1 monoclonal antibody 58 antineoplastic agents 58 interferon γ 58 YONDELIS 58 receptor inhibitor 58 Sudhir Agrawal D.Phil 58 Janus Kinase 58 bevacizumab Avastin R 58 beta lactamases 58 EpCAM 58 proteolytic cleavage 58 bortezomib Velcade 58 partial agonist 58 tumor vascular disrupting 58 PLX cells 58 compound AEZS 58 Akt phosphorylation 58 antimitotic 58 thymalfasin 58 #HT#A 58 tkRNAi 58 pertussis toxin 58 serine protease 58 SinuNase 58 ALN TTR 58 HuMax 58 estrogen receptor beta 58 dasatinib Sprycel ® 58 delivered RNAi therapeutic 58 protective antigen 58 receptor agonist 58 viral proteins 58 P#X# antagonist 58 HER pathway 58 oncoprotein 58 etanercept Enbrel 58 cannabinor 58 anti phosphatidylserine 58 AAV vectors 58 BN# [002] 58 inhibit EGFR 58 demethylating agent 58 antigen rPA anthrax 58 SGLT 58 TGF ß 58 metastatic neuroendocrine tumors 58 proteinase 58 tafamidis 58 lymphoid organs 58 humanised antibody 58 vivo potency 58 Shigamabs ® 57 cetuximab Erbitux R 57 Kahalalide F 57 adenovirus vectors 57 TRISENOX ® 57 novel peptides 57 mutational status 57 VEGF receptor inhibitor 57 Corgentin 57 NMDA antagonist 57 PGL# 57 chlamydial 57 Modified Vaccinia Ankara MVA 57 Protexia ® 57 Chemokine 57 topoisomerase 57 β2 57 romazarit 57 murine mouse 57 activated lymphocytes 57 omega interferon 57 HER2 overexpression 57 PC# cells 57 eniluracil 57 p# MAPK 57 developing TB4 57 uPAR 57 Monoclonal Antibody 57 antigenic peptide 57 selective orally bioavailable 57 P2Y 57 NOD mouse 57 sd rxRNA 57 CXCR4 57 targeting PCSK9 57 LNPs 57 indibulin 57 Qdot 57 small molecule glucokinase 57 Human cl 57 neurotrophic 57 imatinib Gleevec ® 57 sodium glucose transporter 57 Virulizin R 57 NK1 57 phosphate S1P 57 XYOTAX TM 57 pathophysiological effects 57 T#M mutation 57 CCL# 57 USP# 57 EGFR HER2 57 dependent cellular cytotoxicity 57 Recombinant Human 57 POTELLIGENT ® 57 Ofatumumab 57 small molecule activator 57 mecamylamine 57 HepDirect 57 PROfusion 57 Alocrest 57 Zolinza 57 Ganciclovir 57 ganetespib 57 methionine aminopeptidase 57 mannose 57 purified protein 57 gene inactivation 57 osteoclast 57 Potelligent Technology 57 BRAF inhibitor 57 xenograft models 57 Ramoplanin 57 synthetic siRNA 57 Dendritic Cell 57 peptide conjugated 57 carbohydrate polymers 57 Olaparib 57 telomerase activator 57 selective immunoproteasome inhibitor 57 TLK# 57 IFN β 57 thymidine kinase 57 ProMune 57 elotuzumab 57 TH# [003] 57 beta lactam 57 Zalypsis 57 cytotoxicity assays 57 SGLT 2 57 Panzem R 57 HGS ETR1 mapatumumab 57 cholesteryl ester transfer 57 Bruton tyrosine kinase Btk 57 ERK pathway 57 delta isoform 57 CYT# potent vascular disrupting 57 Receptors GPCRs 57 effector functions 57 histone deacetylase HDAC inhibitors 57 antimetabolite 57 rhIL 7 57 muscarinic receptor 57 taxane derivative 57 Chinese Hamster Ovary 57 GV# [001] 57 DAS# [001] 57 immunoglobulin Ig 57 Specifid 57 von Willebrand factor 57 rituximab Rituxan 57 glycogen synthase kinase 57 bortezomib Velcade ® 57 deacetylation 57 ligand TRAIL 57 CR# vcMMAE 57 somatostatin 57 lymphoid cells 57 Erlotinib 57 Factor Receptor 57 4E BP1 57 lysate 57 peptidic compound 57 mouse xenograft models 57 HDAC6 57 inhibit viral replication 57 ALK inhibitor 57 StemEx 57 E#F# 57 ribonuclease 57 EP #R 57 peptibody 57 FGFR4 57 Preclinical studies suggest 57 IGF 1R 57 #beta HSD1 57 cell lysate 57 diphosphate 57 tezampanel NGX# 57 Thrombin 57 Intravenous Human 57 tolerogenic 57 Vacc 4x